Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-08-16

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and adenosine kinase

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with adenosine kinase in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coyle, TS; Kaplan, GB1
Khoo, HE; Mittal, RA; Tan, CH1

Other Studies

2 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and adenosine kinase

ArticleYear
Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation.
    European journal of pharmacology, 1998, Nov-27, Volume: 362, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine Kinase; Animals; Body Weight; Caffeine; Deoxyadenosines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Morphine; Receptors, Purinergic P1; Substance Withdrawal Syndrome

1998
Adenosine modulates cell growth in baby hamster kidney (BHK) cells.
    BioFactors (Oxford, England), 2000, Volume: 11, Issue:4

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adenosine Kinase; Animals; Cell Division; Cell Line; Cricetinae; Enzyme Inhibitors; Kidney; Mutation; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles

2000